3

FORM 3 SUBMISSION

Company: SELLAS Life Sciences Group, Inc.
Filed: December 29, 2017
Period of Report: December 29, 2017
Accession Number: 0001209191-17-067648

View Document ↗ View on SEC.gov ↗